Group 1 - Cencora is merging its subsidiary MWI Animal Health with privately held Covetrus, valuing the deal at $3.5 billion [1] - The transaction aims to allow Cencora to focus more on its core business [1] - Upon completion of the deal, Cencora will receive $1.25 billion in cash, $800 million in preferred stock, and $1.45 billion in common stock, while retaining a 34.3% non-controlling interest in the merged company [1]